SEE FULL COMPANY PROFILES WITH A FREE TRIAL
EMIS is the definitive emerging markets news, research, company, and financial data resource. EMIS - ISI Emerging MarketsLEARN MORE
Search for another company:
ALL
Romania
Company data displayed is for sample purposes only and may not reflect the most current information available on Emerging Markets Information Service (EMIS).

Pharmafarm

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers

facebook Please check the full coverage of information what EMIS can offer you. SEE SAMPLE

Company Information

Full name
Pharmafarm SA

Previous name(s)
Napofarm (1999)

Headquarters
2, Maiakovski St.; CLUJ-NAPOCA; Cluj
Status: Delisted
Legal Form: Public Limited Company
Operational Status: Operational
CUI: 00200106
Financial Auditors: PricewaterhouseCoopers (2010)
Incorporation Date: January 1, 1991
Total Employees: 413

Tel: 00 40-264-436.747

Company Description

Before 1990 entire pharmaceutical wholesale and retail market was organized based on 17 regional "pharmaceutical offices" and Napofarm was the one to cover 3 counties around Cluj. PharmaFarm became the new name of Napofarm in 1999 when PharmaTech acquired Napofarm - regional player state owned - and transform it into a national distribution company.
PharmaFarm has a distribution network of 7 warehouses (Bucharest, Cluj-Napoca, Brasov, Timisoara, Iasi, Galati, Craiova).
PharmaFarm is the
More

Company Analysis

According to the Individual - Non-Audited financial statement for the Year of 2011, total net operating revenues decreased with -8.52%, from RON 331,728,769 to RON 303,471,565 . Operating result decreased from RON -8,713,240 to RON -31,544,896 which means -262.03% change. The results of the period decreased -183.99% reaching RON -35,790,671 at the end of the period against RON -12,602,740 last year. Return on equity (Net income/Total equity) went from -14.03% to -66.20%, the Return On Asset (Net income / Total Asset) went from -3.30% to -9.59% and the Net Profit Margin (Net Income/Net Sales) went from -3.80% to -11.79% when compared to the same period of last year. The Debt to Equity Ratio (Total Liabilities/Equity) was 590.55% compared to 325.57% of last year. Finally, the Current Ratio (Current Assets/Current Liabilities) went from 1.60 to 1.19 when compared to the previous year.

Key Executives

Hazlinszky Peter Istvanne General Manager
Ionela Stanciulescu Financial Director
Catalina Ciubotaru Director of Human Resources
Liviu Rebreanu Logistics Manager

Companies with Similar Main Activities

ISI Emerging Markets

FULL COMPANY PROFILE

Please check the full coverage of information what EMIS can offer you.
SEE SAMPLE
SELECT CURRENCY
Balance Sheet

Total Assets

373,334,955

382,390,447

Current Assets

339,356,648

332,575,183

Total Liabilities

319,271,441

292,536,262

Shareholders Equity

54,063,514

89,854,185

Current Liabilities

284,720,440

207,528,374

* All the accounts are in RON.
Income Statement

Total Operating Revenue

303,471,565

331,728,769

Operational Profit (Loss)

-31,544,896

-8,713,240

Net Profit (Loss)

-35,790,671

-12,602,740

* All the accounts are in RON.
Ratios
Profitability Ratios

Return on Assets (ROA)

-9.59%

-3.30%

Annualised Return on Assets (ROA)

-9.59%

-3.30%

Return on Equity (ROE)

-66.20%

-14.03%

Annualised Return on Equity (ROE)

-66.20%

-14.03%

Return on Sales (ROS)

-11.83%

-3.81%

Return on Capital

-40.39%

-7.21%

Gross Profit Margin

0.69%

1.96%

Operating Profit Margin

-10.42%

-2.64%

Efficiency Ratios

Accounts Receivable Turnover

1.15x

1.22x

Inventory Turnover

5.36x

6.57x

Current asset turnover

0.89x

0.99x

Fixed-asset turnover

8.91x

6.63x

Asset Turnover

0.81x

0.86x

Valuation figures and ratios

Earning Before Interests and Taxes (EBIT)

-31,544,896

-8,713,240

EBITDA

-27,421,424

-4,630,149

Bookvalue (BV)

53,610,191

88,903,099

Net Cash

-265,335,573

-195,174,299

Liquidity Ratios

Current Ratio

119.12%

160.23%

Quick ratio

99.43%

136.47%

Doom's day ratio

6.81%

5.95%

Leverage Ratios

Leverage ratio

690.55%

425.57%

Interest Coverage Ratio

-642.22%

-206.04%

Debt to equity

582.38%

322.22%

Debt to total assets

84.34%

75.72%

Long Term Debt to Capital

21.91%

43.30%